Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Gilteritinib is suitable for Leukemia.【more】
Release date：2026-01-06Recommended：30
Capmatinib is indicated for the treatment of adult patients with metastatic non-···【more】
Release date：2026-01-06Recommended：111
Treatment of refractory relapsed multiple myeloma and certain types of diffuse l···【more】
Release date：2026-01-06Recommended：60
It is indicated for patients with susceptible isocitrate dehydrogenase-1 (IDH1) ···【more】
Release date：2026-01-06Recommended：68
Exkivity is suitable for specific non-small cell lung cancer(NSCLC).【more】
Release date：2026-01-06Recommended：57
Broad-spectrum antitumor agents【more】
Release date：2026-01-06Recommended：21
Ixazomab is suitable for the treatment of multiple myeloma.【more】
Release date：2026-01-06Recommended：72
It is mainly used for the treatment of chronic lymphocytic leukaemia (CLL), smal···【more】
Release date：2026-01-06Recommended：40
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic p···【more】
Release date：2026-01-06Recommended：65
司帕生坦、Sparsentan、LuciSeta、Filspari、斯帕森坦【more】
Release date：2026-01-06Recommended：75
Suitable for treating severe alopecia areata in adults and adolescents aged 12 a···【more】
Release date：2026-01-06Recommended：10
Used for the treatment of advanced, unresectable cholangiocarcinoma with FGFR2 g···【more】
Release date：2026-01-06Recommended：39
